SEC Form 3

FORM 3

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0104 Estimated average burden hours per response: 0.5

1. Name and Address of Reporting Person* Firestone Gregory A. (Last) (First) (Middle) C/O TELA BIO, INC. 1 GREAT VALLEY PARKWAY, SUITE 24 (Street) MALVERN PA 19355 (City) (State) (Zip)	2. Date of Event Requiring Statement (Month/Day/Year) 08/03/2023	3. Issuer Name and Ticker or Trading Symbol TELA Bio, Inc. [ TELA ]
		4. Relationship of Reporting Person(s) to Issuer (Check all applicable) Director 10% Owner X Officer (give title below) Other (specify below) Chief Business Officer	5. If Amendment, Date of Original Filed (Month/Day/Year)
			6. Individual or Joint/Group Filing (Check Applicable Line) X Form filed by One Reporting Person Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4)	2. Amount of Securities Beneficially Owned (Instr. 4)	3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	4. Nature of Indirect Beneficial Ownership (Instr. 5)
Common Stock	14,961	D

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4)	2. Date Exercisable and Expiration Date (Month/Day/Year)		3. Title and Amount of Securities Underlying Derivative Security (Instr. 4)		4. Conversion or Exercise Price of Derivative Security	5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5)	6. Nature of Indirect Beneficial Ownership (Instr. 5)
	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	(1)	11/01/2027	Common Stock	31,793	5.93	D
Stock Option (Right to Buy)	(1)	02/28/2028	Common Stock	2,308	5.93	D
Stock Option (Right to Buy)	(2)	11/07/2029	Common Stock	45,362	13	D

Explanation of Responses:

1. The shares subject to this option are fully vested and exercisable.

2. The option vested 25% on November 7, 2020, with the remaining 75% vesting in equal monthly installments on the last day of each of the 36 calendar months immediately following such date, subject to the Reporting Person's continued service through the applicable vesting dates.

Remarks:

Exhibit List - Exhibit 24 - Power of Attorney

	/s/ Megan Smeykal, Attorney-in-fact	08/04/2023
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

POWER OF ATTORNEY

   KNOW ALL BY THESE PRESENTS, that the undersigned hereby
constitutes and appoints the Chief Executive Officer, the
Chief Financial Officer and the Chief Accounting Officer
with full power to act as the undersigned's true and
lawful attorneys-in-fact, with full power of substitution,
to:
	1) execute for and on behalf of the undersigned,
in the undersigned's capacity as an officer and/or director
and/or beneficial owner of TELA Bio, Inc. (the "Company"),
the Forms 3, 4 and 5 in accordance with Section 16(a) of the
Securities Exchange Act of 1934, as amended, and the rules
thereunder;
	2) do and perform any and all acts for and on behalf
of the undersigned which may be necessary or desirable to
complete and execute any such Forms 3, 4 and 5, complete and
execute any amendment or amendments thereto, and timely file
such form with the United States Securities and Exchange
Commission and any stock exchange or similar authority; and
	3) take any other action of any type whatsoever in
connection with the foregoing which, in the opinion of such
attorney-in-fact, may be of benefit to, in the best interest
of, or legally required by, the undersigned, it being
understood that the documents executed by such attorney-in-fact
on behalf of the undersigned pursuant to this Power of Attorney
shall be in such form and shall contain such terms and
conditions as such attorney-in-fact may approve in such
attorney-in-fact's discretion.
   The undersigned hereby grants to the attorney-in-fact full
power and authority to do and perform any and every act and
thing whatsoever requisite, necessary or proper to be done in
the exercise of any of the rights and powers herein granted, as
fully to all intents and purposes as the undersigned might or
could do if personally present with full power of substitution
or revocation, hereby ratifying and confirming all that such
attorney-in-fact or such attorney-in-fact's substitute or
substitutes shall lawfully do or cause to be done by virtue of
this power of attorney and the rights and powers herein granted.
   This power of attorney shall remain in full force and effect
until revoked by the undersigned in a signed writing delivered
to the attorney-in-fact.
   IN WITNESS WHEREOF, the undersigned has caused this Power
of Attorney to be executed as of this 7th day of July, 2023.

      By:	/s/ Gregory A. Firestone
      Name:	Gregory A. Firestone